In a surprising turn of events, the FDA has allowed Sarepta Therapeutics to resume shipments of its gene therapy, Elevidys, for younger Duchenne muscular dystrophy patients who can walk, despite concerns over previous fatalities.
The EU has recommended lenacapavir, an injectable drug for HIV prevention, which could drastically reduce transmission rates. With nearly 100% effectiveness, it promises a new era in combating HIV.
The European Medicines Agency has recommended the approval of lenacapavir, a twice-yearly injectable drug that could revolutionize HIV prevention and significantly reduce transmission rates globally.
Paramount Global is set to finalize its $8bn merger with Skydance Media, marking a pivotal shift in the entertainment industry under the Trump administration's influence. The merger's approval has raised eyebrows amidst political tensions and a recent lawsuit settlement with Trump.
The FCC has greenlit the $8 billion merger between CBS's parent company Paramount and Skydance Media, amidst accusations of political influence and promises of reform in news coverage.
Sarepta Therapeutics' gene therapy for Duchenne muscular dystrophy is on hold due to safety issues. An FDA official warns the path to market approval is fraught with challenges, especially after patient deaths linked to liver injuries.
As the Epstein scandal looms, Trump stirs controversy with demands for the Washington Commanders to change their name. Critics suggest he's trying to distract from pressing issues. Can he handle the heat?
Jon Stewart expresses uncertainty about the future of The Daily Show in light of the Skydance-Paramount merger. He reflects on the show's value amidst industry changes and recent cancellations.
In a historic move, the House has approved President Trump's request to cut $9 billion from public broadcasting and foreign aid, raising concerns among Democrats and some Republicans. This unprecedented action could reshape funding priorities and affects essential services.
The House has voted to cut $9 billion in funding, eliminating federal support for NPR and PBS. This controversial decision faces backlash from both sides of the aisle, raising concerns over the future of public broadcasting.
